M&A Deal Summary |
|
|---|---|
| Date | 2011-02-02 |
| Target | Palace Cinemas B.V. |
| Sector | Media |
| Buyer(s) | Cinema City International N.V. |
| Sellers(s) | Argus Capital Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Media M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Hungary M&A | 1 of 1 |
| Year: 2011 M&A | 1 of 1 |
| Category | Private Equity Firm |
|---|---|
| Founded | 1998 |
| PE ASSETS | 433M EUR |
| Size | Middle-Market |
| Type | Sector Agnostic |
ARGUS Capital Partners is a private equity firm focused on investing throughout Central and Eastern Europe, including Albania, Bosnia & Herzegovina, Bulgaria, Croatia, the Czech Republic, Estonia, Hungary, Latvia, Lithuania, Macedonia, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia, and Turkey. ARGUS does not have any industry preferences and can support a variety of transaction situations. Prospective transaction types include buyouts, growth capital financings, and industry consolidations. The Firm's target investment size is €10 to €40 million. ARGUS Capital was formed in 1998 and is based in London.
| DEAL STATS | # |
|---|---|
| Overall | 5 of 8 |
| Sector: Media M&A | 3 of 3 |
| Type: Add-on Acquisition M&A Deals | 3 of 5 |
| Country: Hungary M&A | 2 of 2 |
| Year: 2011 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-12-01 |
KaleNobel
Istanbul, Turkey KaleNobel is a consumer packaging company focused on the manufacture of flexible consumer packaging for ice cream and other applications as well as aseptic cartons. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2011-07-25 |
KCR Co.
Warsaw, Poland KCR is the largest Polish-owned firm in the CRO sector (a Contract Research Organization - a company which conducts clinical trials). Since its beginning, KCR has conducted over 300 clinical trials in 7,500 centres, in which over 300,000 patients have participated. The company conducts phase II-IV clinical trials (mostly phase III studies), including tests in neurology, psychiatry, internal and contagious diseases, pulmonology, cardiology and gastrology. KCR has performed studies for a diverse mix of clients (large global pharma co's, mid-size regional pharma players, and biotech companies). |
Buy | - |